Form 4 for HUM Humana
Accepted 2025-02-26 00:00:00 ET · period of report 2025-02-24 · accession 0001062993-25-003577 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| I | 2025-02-26 | 2025-02-24 | HUM | Rechtin James A. | Pres, CEO | A - Grant | $0.00 | +19.0K | 23.9K | +388% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Humana Common | 2025-02-24 | A | A | 19,037 | $0.00 | 23,944 | I See Footnote | — | — | (F6) Includes 21,761 restricted stock units representing a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan. (F1) All shares held in two revocable trust(s) for the benefit of reporting person and reporting person's spouse, with reporting person and spouse being sole trustees. |